The Hidden Danger of IgAN: Pathogenesis and Unmet Needs
Jonathan Barratt, MD, PhD
Decoding IgA Nephropathy: From Suspicion to Solution
Chee Kay Cheung, MBChB, MRCP, PhD
An De Vriese, MD, PhD
Jörg Latus, MD
Unmasking IgAN: Achieving Earlier Diagnosis
Proteinuria in IgAN: The Signal, The Target, and the Treatment Goal
The Future of IgAN Care
The Evolving Role of Biomarkers in IgAN
Engaging Patients With Heart Failure and Chronic Hyperkalemia: Shared Decision-Making to Support Guideline-Directed Medical Therapy
Gianluigi Savarese, MD, PhD, FESC, FHFA
Itching for Answers: Holistic CKD-aP Care
Steven Fishbane, MD
Federico Alberici, MD, PhD
Nancy Helou, PhD
Anastasia Liossatou, PhD, RN
CKD-aP Uncovered Prevalence & Pathophysiology
Spotlight on Assessment: Tools That Capture CKD-aP
Frontline Champions: Nurses as Drivers of Symptom-Based CKD-aP Care
From Scratch to Strategy: Talking About CKD-aP in Clinical Practice
Winning the CKD-aP Battle: A United Physician-Nurse Front
Crossing Home Plate – Building a Winning Team Culture
J.A. Randy Englert, MD, FACC
Matthew Malachowski, Pharm. D., MHA
Swing for the Fences – LDL-C as the Power Hitter
Translating the Latest KDIGO Guidelines Into Practice: IV Iron Therapy in Patients With Non–Dialysis-Dependent CKD
Patrick Rossignol, MD, PhD
Julio Núñez, MD, PhD